AstraZeneca and Bristol Myers Squibb reportedly in merger talks
AstraZeneca is reportedly in discussions with Bristol Myers Squibb regarding a potential merger, which could represent one of the largest deals ever in the biopharmaceutical industry. The Financial Times reported the talks, though a deal is not guaranteed.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.